Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, November 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 1 X post from an account with 41 followers.

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. https://t.co/3A2zBujXgw